Investors Urged to Join Class Action Against Hims & Hers Health, Inc. Over Alleged Misleading Practices

Class Action Lawsuit Filed Against Hims & Hers Health, Inc.

On July 7, 2025, The Gross Law Firm announced a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) focusing on accountability for shareholders who purchased shares during a specified time frame. This lawsuit highlights allegations of misleading statements and deceptive practices that supposedly jeopardized investors' financial interests and patient safety.

Background of the Lawsuit

The notice from The Gross Law Firm indicates that the class period for this lawsuit extends from April 29, 2025, to June 23, 2025. During this period, it is alleged that Hims & Hers Health, Inc. issued statements which were materially misleading. The firm emphasizes serious concerns pertaining to the promotion of what they call "illegitimate, knockoff versions of Wegovy®"—a weight loss medication produced by Novo Nordisk that has gained popularity for its effectiveness. The allegations suggest that this concerning practice not only placed patients’ health at risk but might have also threatened the continuity of Hims’ collaboration with Novo Nordisk.

As the lawsuit unfolds, the Gross Law Firm calls out the possibility that the favorable statements made by Hims & Hers about their business operations and prospects were significantly unfounded. Investors are urged to recognize the urgency of this situation and take proactive steps to safeguard their financial interests.

What Shareholders Should Do

Shareholders who bought shares in the specified timeframe are encouraged to reach out to The Gross Law Firm. Those interested in leading the class action or simply participating are invited to register using the provided link from the firm's notice. Importantly, lead plaintiff status is not a prerequisite for participating in any recovery, allowing more shareholders the opportunity to contribute to this legal effort without necessarily leading the charge.

The deadline to register as a lead plaintiff is August 25, 2025. Shareholders are advised not to delay as timely registration is crucial for maintaining their rights and potential claims related to this case.

Once registered, shareholders will gain access to an innovative portfolio monitoring software that will enable them to stay updated on the lawsuit's progression. The service ensures that they remain informed throughout each stage of the class action.

Why Join the Class Action?

The Gross Law Firm stresses the importance of its mission: advocating for investors who have suffered losses due to corporate malfeasance and fraud. This class action lawsuit is aimed at holding companies accountable for their business practices and safeguarding the rights of shareholders. The firm's commitment to ensuring ethical conduct within corporate America illustrates not only its dedication to investor rights but also the broader implications for corporate conduct in general.

Join the Fight

In today's market, the integrity of a company's operations can profoundly influence stock prices and investors' peace of mind. For those who feel their interests have been compromised by Hims & Hers Health, Inc., participating in this class action can be a vital step toward recovery. As this lawsuit develops, investors are reminded that they do not have to navigate this complex landscape alone; legal support is available to guide them on their path forward.

For more information and to initiate participation in this class action against Hims & Hers, shareholders are encouraged to contact The Gross Law Firm directly via their provided resources.

In conclusion, as the deadline approaches, it is imperative for impacted investors to take action to ensure their voices are heard and their rights are protected in the evolving landscape of corporate accountability.